Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Journal of Gastrointestinal Oncology|September 16, 2024
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort studyCan Chen, Xi Luo, Wenhua Tang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 29, 2023
Age-Specific Differences in the Risk of Colorectal Precursor Lesions Among Patients with Type 2 Diabetes Undergoing Surveillance ColonoscopyReger R Mikaeel, Suzzane Edwards, Jean M Winter, et al.
Journal of Medical Imaging and Radiation Oncology|July 12, 2016
MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trialKirsten L Gormly, Claudio Coscia, Tim Wells, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 1, 2017
Liver resection for colorectal cancer metastases: a comparison of outcomes over time in South AustraliaAsma Sultana, Rosie Meng, Cynthia Piantadosi, et al.
Clinical Colorectal Cancer|February 5, 2019
Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX TrialGonzalo Tapia Rico, Timothy Price, Niall Tebbutt, et al.
ANZ Journal of Surgery|October 8, 2014
Improving care for patients with oesophageal and gastric cancer: impact of a statewide multidisciplinary teamEleanor E Wilson, Sarah K Thompson, Jeff Bull, et al.
Clinical Colorectal Cancer|September 14, 2019
Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab TrialsJulien Taieb, Michael Geissler, Fernando Rivera, et al.
Expert Review of Anticancer Therapy|December 24, 2024
Role of locoregional therapy including liver transplantation in liver-only metastatic colorectal cancer: a review paperLaura Depauw, Amanda Townsend, Christos Karapetis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2018
Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in <i>KRAS</i> Wild-Type Metastatic Colorectal CancerAmanda Townsend, Niall Tebbutt, Christos Karapetis, et al.
Asia-Pacific Journal of Clinical Oncology|October 26, 2024
Expert consensus on the optimal management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in the Asia-Pacific regionOliver Piercey, Lorraine Chantrill, Hung-Chih Hsu, et al.
Pageof 13